New Items

Approx. Rs 400 / BoxGet Latest Price

Amoxyheal CV 1000 mg (Amoxicillin 875 mg + Potassium Clavulanate 125 mg)

Description:
Amoxyheal CV is a fixed‑dose combination antibiotic combining amoxicillin (a penicillin-class antibiotic) with clavulanate, a β‑lactamase inhibitor. This duo enhances amoxicillin’s effectiveness against bacteria that produce resistance enzymes 

Indications:

• Upper/lower respiratory infections (sinusitis, otitis media, bronchitis, pneumonia)

• Skin, soft tissue, bone & joint infections

• Urinary tract infections, cystitis, pyelonephritis

• Dental, gingival, wound, and abscess infections 

Mechanism of Action:

• Amoxicillin inhibits bacterial cell‑wall synthesis → bacterial death

• Clavulanate inhibits β‑lactamase enzymes → protects 

Dosage & Administration:

• For adults & children ≥40 kg: 1 tablet (875 mg/125 mg) orally with food, every 12 hours, as prescribed

• Duration varies by infection type (typically 5–14 days); always complete full course to limit resistance 

Side Effects:
Common: diarrhea, nausea, vomiting, abdominal discomfort, skin rash, headaches
Less common/serious: candidiasis, allergic reactions, rare cholestatic jaundice (usually in older males or prolonged use) 

Precautions & Contraindications:

• Contraindicated in patients with penicillin hypersensitivity

• Use cautiously if history of liver dysfunction or cholestatic jaundice

• May interact with oral contraceptives, probenecid

• Uncommon but possible Clostridioides difficile–associated diarrhea 

Storage & Handling:

• Store at room temperature, protected from heat and moisture

• Keep out of reach of children; tablets should be swallowed whole 

Monitoring & Follow‑up:

• Evaluate for symptom relief within 48–72 hours; if no improvement or side effects occur, consult a physician

• Consider liver and renal function tests in prolonged therapy

Note:
This effective broad-spectrum antibiotic should be used only for confirmed or strongly suspected bacterial infections. Misuse or incomplete courses can foster antibiotic resistance. Use under medical supervision.

Approx. Rs 500 / StripGet Latest Price

Mitra 30

Mitra 30 contains Mirtazapine 30 mg, an antidepressant classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It enhances the activity of norepinephrine and serotonin by blocking central alpha-2 adrenergic receptors and selectively antagonizing certain serotonin receptors. It is used to treat major depressive disorder and may also help with anxiety, insomnia, and appetite loss.

Indications:

• Major depressive disorder (MDD)

• Generalized anxiety disorder (off-label)

• Insomnia or poor appetite associated with depression

Dosage:
Usually taken once daily at bedtime due to its sedative effects. The typical dose ranges from 15–45 mg/day. Mitra 30 provides an intermediate therapeutic dose.

Side Effects:
Drowsiness, increased appetite, weight gain, dry mouth, dizziness, and constipation. Rare but serious effects include low white blood cell count and suicidal thoughts, especially in young adults.

Precautions:
Use cautiously in liver or kidney impairment, seizure disorders, or bipolar disorder. Avoid alcohol and CNS depressants. Not recommended during pregnancy or breastfeeding unless necessary.

Always use under psychiatric supervision.